Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-04-21
2011-11-01
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S130100, C424S184100, C424S185100, C424S234100, C435S004000, C435S007100, C435S007200
Reexamination Certificate
active
08048434
ABSTRACT:
The invention relates to a novel adjuvantMycobacteriumw and or its constituents and adjuvant containing composition, which contains antigen (s) with pharmaceutical acceptable carrier and its uses.Mycobacteriumw and or its constituents when administered with antigen (s) to mammal results in enhanced immunogenicity of antigen. The enhanced immunogenicity manifests as humoral responses as well as cell mediated immunity. The adjuvant effect is seen with variety of antigens in various mammals irrespective of their immune status at the time of administration ofMycobacteriumw and antigen containing composition. e.g. immune naïve or preimmunized status.
REFERENCES:
patent: WO02/056898 (2002-07-01), None
patent: WO03/049667 (2003-06-01), None
patent: WO03/075825 (2003-09-01), None
Desai Nirav
Ghosh Prasanta Kumar
Khamar Bakulesh Mafatlal
Modi Indravadan Ambalal
Modi Rajiv Indravadan
Burns & Levinson LLP
Cadila Pharmaceuticals Ltd.
Swartz Rodney P.
LandOfFree
Vaccine adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine adjuvants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4306730